[303 Pages Report] The global virology specimen collection market size was valued at US$ 5.6 Billion in 2021 and is estimated to experience a negative CAGR of -0.5% during the forecast period of 2022 to 2032.
Growth of the market can be attributed to:
During the COVID-19 pandemic, the growth of the market was stagnated owing to nation wide lockdowns. On the other hand, testing of virus specimens became essential owing to the urgent need for curbing viruses.
Technological advancements in the field of specimen collection have made it easier for exchange of information regarding viruses. As the nature of viruses differ from region to region owing to mutation of the same, the market for virology specimen collection has gained traction.
The outbreak of Zika virus and Babesia alongside announcements for their inclusion in virology specimen collection tests have indicated the need for innovation in virology specimen collection technologies, consumables, and instruments.
Other countries have also undertaken initiatives to check for new and emerging diseases. In addition, the prevalence of EBOLA, Zika virus, SARS-CoV-2, AIDS, flu, and STDs is driving the growth for virology specimen collection market.
| Attributes | Details |
|---|---|
| Virology Specimen Collection Market CAGR (2022 to 2032) | -0.5% |
| Virology Specimen Collection Market (2026) | US$ 5.3 Billion |
| Virology Specimen Collection Market Attraction | Innovation in specimen collection devices technologies to keep the global market attractive |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
High awareness levels regarding the disease transmission, diagnosis, and effective management of microbial infections have been observed in North America. In addition, government initiatives to support product development for virology specimen collection is influencing market growth.
In addition, large share of North America in this market can be attributed to the increasing adoption of NAT (due to the high prevalence of TTIs). Furthermore, technological developments including portable diagnostics is favoring the growth of the market.
Growing income levels, greater health awareness, and the rising incidence of lifestyle diseases is contributing to the growth of virology specimen collection market. Currently, ELISA is widely used in India, with NAT registering relatively low penetration.
Emerging markets such as India, the Middle East, and Africa offer promising opportunities for players in the virology specimen collection industry due to their increasing disposable incomes and improving healthcare infrastructure.
NAT is still not mandatory in India, thus, states in India are using NAT in ID-NAT format. For Instance, AIIMS, PGI Chandigarh, CMC Vellore, Medanta-The Medicity, and Narayana Hrudayalaya, are using, and 40 blood banks are using the pooling technique. Similarly, the Indian government is taking initiatives to train doctors, hospitals, and blood banks to use NAT.
On the other hand, regions like US, Canada, most of Europe, Japan, Korea, Singapore, Sri Lanka, UAE, South Africa, Thailand, and China. Almost 100 blood banks are using Nat for virology specimen collection.
"The growth virology specimen collection market has stagnated in recent times because of the diverted focus of public healthcare resources towards the detection of widespread coronavirus infections."
The frequent outbreak of viral diseases in different parts of the world has provided the necessary impetus for adopting successful innovations in the virology specimen collection processes and devices. Market players in the high-income countries are at the forefront of taking advantage of these facilities to dominate the global microbiology specimen collection market.
Principal Consultant
COVID has had a minor to moderate impact on the virology specimen collection market. As curfews and social isolation become less stringent, demand is likely to rise, resulting in a market deficit. On the other hand, governments around the world are taking steps to raise donations during the anticipated period to meet the unexpected surge in demand for laboratory testing following the lockdown.
Furthermore, the increased frequency of viral infections such as SARS-CoV-2, AIDS, flu, EBOLA, Zika virus, and STDs is fuelling demand for efficient virology specimen collection.
“ELISA is a main source for diagnosis because of its affordability, although enhanced sources are still prohibitively expensive, posing a market problem.”
In the short term, relying on ELISA is a crucial impediment to the growth of NAT's virology specimen collection market. Due to the high expense of sophisticated testing, earlier, less efficient tests, such as first-generation ELISA, are being used more frequently. Flu, Zika virus, STDs, AIDS, and Ebola virus public awareness campaigns are also a crucial component in raising public knowledge and, as a result, affecting the market growth.
While it is encouraging that new diagnostic techniques are becoming accessible to improve clinical treatment in low-resource settings, the cost of each test is a significant barrier to acceptance and long-term use.
Only giant corporations can afford significant capital expenditures and high R&D and manufacturing costs. New entrants will be unable to enter the market due to this.
“The demands a decrease in the cost of microbiology specimen collection products will continue to stifle market expansion until it is met and overcome.”
The epidemics of Zika and Babesia and news that they would be included in virology specimen collecting tests highlight the need for new microbiology specimen collection technologies, consumables, and equipment. Other governments have launched their efforts to monitor new and emerging illnesses.
The prevalence of malaria in African countries, collection, transportation, and storage of samples for viral diagnosis and the risk of Zika virus transmission via mosquitos has resulted in regulations for Zika virus screening across the region. Various medium solutions have been suggested for stabilizing specimens to identify bacteria and viruses, especially during diagnostic investigations.
To strengthen pandemic management, microbiology specimen collection and future preparedness for COVID-19 and other infectious diseases, international strategies for the regulation, evaluation, and use of digital technologies such as digital epidemiological surveillance, rapid case identification, interruption of community transmission, transport of viral specimen and future preparedness for COVID-19 and other infectious diseases must be aligned.
A variety of protein supplements have been and continue to be prescribed to improve viral stability. These are generally made up of balanced salt or saline solutions with a buffering ability to keep the pH close to neutral. While some laboratories collect, transport, and store samples for viral diagnosis, commercial preparations are often utilized and generally come with sterile swabs as part of a sample collection kit.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Virology Specimen Collection Market:
| Attributes | Virology Specimen Collection Market |
|---|---|
| CAGR (2022 - 2032) | -0.5% |
| Market Value (2026) | US$ 5.3 Bn |
| Growth Factor | Rising awareness about blood donations to drive high demand for virology specimen collection devices. |
| Opportunity | Outbreak of COVID-19 and continuous mutations to provide market opportunities. |
| Key Trends | Partnerships and product launches are the pathway to inorganic growth. |
Virology Market:
| Attributes | Virology Market |
|---|---|
| CAGR (2022 - 2032) | 3.6% |
| Market Value (2026) | US$ 5.2 Bn |
| Growth Factor | Availability of portable devices with rapid results to facilitate market growth. |
| Opportunity | Improvement in safety and quality standards to remain the key. |
| Key Trends | Extending R&D capabilities to offer huge opportunities. |
Viral Molecular Diagnostics Market:
| Attributes | Viral Molecular Diagnostics Market |
|---|---|
| CAGR (2022 - 2032) | 9% |
| Market Value (2026) | US$ 20 Bn |
| Growth Factor | Affordability of diagnostics procedure to grow demand in Asia Pacific. |
| Opportunity | Advanced healthcare infrastructure to intensify focus of players on North America. |
| Key Trends | Popularity of personalized medicines to drive adoption. |
Factors such as the expanding number of blood donations, the rising frequency of viral illnesses, and the advent of emerging pathogens are increasing the frequency of virology sample collection.
Due to a rise in demand for COVID-19 diagnostic testing, multiple manufacturers have increased the capacity of viral screening tests products worldwide. As a result, the bacterial and viral diagnostic testing sector is booming. The market for bacterial and virology specimen collection industry insights project the market to be driven by critical firms developing technologies to enable error-free laboratory-quality specimen collection.
As per the emerging trends in the virology specimen collection market, developing regions such as India, the Middle East, and Africa present lucrative contracts for companies in the virology samples sector due to escalating disposable incomes and promoting health systems.
On the back of rising healthcare costs, blood safety awareness, and the growing number of blood donation campaigns, high-income countries around the world are adopting newer technology.
The high cost of collecting and storing viral specimens is a significant factor limiting the market's growth potential. As newer tests are more expensive, earlier and less efficient tests, such as first-generation ELISA, are being used more frequently. As a result, lowering the pricing of these items is critical to stimulate market demand; otherwise, the virology specimen collection market is expected to be hampered even in the approaching years.
The rising price of technologies and collection, transportation, and storage of samples for viral diagnosis and the use of flow sensitivity screening are limiting the market's development.
“The overall growth of global virology specimen collection market comes from the united growth of virology transport media and nasopharyngeal sample.”
The global market study on the virology specimen collection market is segmented into categories; Product type sample. These categories and their segment’s performance differ with different regions. There are segments like blood collection kits, specimen collection, viral transport media, and swabs based on product type.
Based on the sample, the segments are blood samples, nasopharyngeal samples, throat samples, cervical samples, oral samples and other samples. The services related to it are virology sample collection, laboratory testing and microbiology specimen collection.
The virology specimen collection market report tells that the virology transport media segment is likely to perform better than any other segment of product type categories. The reason behind the growth of this specific segment is the high number of blood donations having all around the world.
Also, the emergence of new pathogens is driving the force behind the sales of virology specimen collection and virology transport media. Consumers are getting aware about the global blood banks with the increasing number of cancer cases, which encourages them to donate blood.
The nasopharyngeal sample segment holds the most significant portion of the market share. The primary reason behind that is the fast detection of transmissible transfusion infection (TTIs) and the increased prevalence of HPV-related cancers (all cervical cancers) & human papillomavirus (HPV).
The transmissible infections led to nasopharyngeal samples more often in the healthcare and medical industry. Emerging trends in the virology specimen collection market also estimate that the nasopharyngeal samples are likely to witness the highest sales post the forecast period.
The market for virology specimen collection is highly consolidated. In the virology specimen collection market, the key players are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific Inc. (US), Trinity Biotech (Ireland), and Titan Biotech Ltd. (India). These key players accounted for a combined majority market share in 2020.
There is fierce competition among Key players in the virology specimen collection market. Only major corporations can afford significant capital expenditures and high R&D and manufacturing costs. New entrants will face difficulties entering the virology specimen collection market due to this.
Along with these considerations comes the requirement for the application of digital technology, such as digital epidemiological surveillance, future preparation for COVID-19 and other infectious illnesses, pandemic management, community transmission interruption, and rapid case identification. As a result of these factors, the virology specimen collection market is expected to have numerous potential opportunities in future years.
The blood sample segment accounts for the highest growth rate.
Asia Pacific is predicted to experience the highest growth rate.
Need for alternative technologies for testing of virology samples is a major restraint.
The growth of the virology specimen collection market is likely to be US$ 5.3 Bn by 2026.
The virology specimen collection market is likely to remain negative during the forecast period.
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Fact.MR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Protective Coatings Market (US$ Mn) 4.2. Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Protective Coatings Market Growth 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 8.3.1. Blood Collection Kits 8.3.2. Specimen Collection Tubes 8.3.3. Viral Transport Media 8.3.4. Swabs 8.4. Market Attractiveness Analysis By Product Type 9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Sample 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Sample, 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample, 2022-2032 9.3.1. Blood Samples 9.3.2. Nasopharyngeal Samples 9.3.3. Throat Samples 9.3.4. Nasal Samples 9.3.5. Cervical Samples 9.3.6. Oral Samples 9.3.7. Other Samples 9.4. Market Attractiveness Analysis By Sample 10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2015-2021 and Forecast 2022-2032 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 11.4.1. By Country 11.4.1.1. U.S. 11.4.1.2. Canada 11.4.1.3. Rest of North America 11.4.2. By Product Type 11.4.3. By Sample 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Product Type 11.5.3. By Sample 12. Latin America Market Analysis 2015-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. Brazil 12.4.1.2. Mexico 12.4.1.3. Rest of Latin America 12.4.2. By Product Type 12.4.3. By Sample 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product Type 12.5.3. By Sample 13. Europe Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. Germany 13.4.1.2. France 13.4.1.3. U.K. 13.4.1.4. Italy 13.4.1.5. Benelux 13.4.1.6. Nordic Countries 13.4.1.7. Rest of Europe 13.4.2. By Product Type 13.4.3. By Sample 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By Sample 14. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. China 14.4.1.2. Japan 14.4.1.3. South Korea 14.4.1.4. Rest of Asia Pacific 14.4.2. By Product Type 14.4.3. By Sample 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By Sample 15. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Turkey 15.4.1.4. Rest of Middle East and Africa 15.4.2. By Product Type 15.4.3. By Sample 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By Sample 16. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.2.2.1. By Product Type 16.2.2.2. By Sample 16.3. Canada Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.3.2.1. By Product Type 16.3.2.2. By Sample 16.4. Mexico Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.4.2.1. By Product Type 16.4.2.2. By Sample 16.5. Brazil Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.5.2.1. By Product Type 16.5.2.2. By Sample 16.6. Germany Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.6.2.1. By Product Type 16.6.2.2. By Sample 16.7. France Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.7.2.1. By Product Type 16.7.2.2. By Sample 16.8. Italy Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.8.2.1. By Product Type 16.8.2.2. By Sample 16.9. BENELUX Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.9.2.1. By Product Type 16.9.2.2. By Sample 16.10. UK Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.10.2.1. By Product Type 16.10.2.2. By Sample 16.11. Nordic Countries Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.11.2.1. By Product Type 16.11.2.2. By Sample 16.12. China Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.12.2.1. By Product Type 16.12.2.2. By Sample 16.13. Japan Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.13.2.1. By Product Type 16.13.2.2. By Sample 16.14. South Korea Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.14.2.1. By Product Type 16.14.2.2. By Sample 16.15. GCC Countries Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.15.2.1. By Product Type 16.15.2.2. By Sample 16.16. South Africa Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.16.2.1. By Product Type 16.16.2.2. By Sample 16.17. Turkey Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.17.2.1. By Product Type 16.17.2.2. By Sample 16.17.3. Competition Landscape and Player Concentration in the Country 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 17.4.1. By Regional footprint of Players 17.4.2. Product footprint by Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive 18.3.1. BECTON, DICKINSON AND COMPANY 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Sales Footprint 18.3.1.4. Strategy Overview 18.3.2. QUIDEL CORPORATION 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Sales Footprint 18.3.2.4. Strategy Overview 18.3.3. THERMO FISHER SCIENTIFIC, INC. 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Sales Footprint 18.3.3.4. Strategy Overview 18.3.4. TRINITY BIOTECH 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Sales Footprint 18.3.4.4. Strategy Overview 18.3.5. TITAN BIOTECH LTD. 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Sales Footprint 18.3.5.4. Strategy Overview 18.3.6. DIASORIN SA 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Sales Footprint 18.3.6.4. Strategy Overview 18.3.7. VIRCELL S.L. 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Sales Footprint 18.3.7.4. Strategy Overview 18.3.8. COPAN 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Sales Footprint 18.3.8.4. Strategy Overview 18.3.9. PURITAN MEDICAL PRODUCTS CO. 18.3.9.1. Overview 18.3.9.2. Product Portfolio 18.3.9.3. Sales Footprint 18.3.9.4. Strategy Overview 18.3.10. HARDY DIAGNOSTICS 18.3.10.1. Overview 18.3.10.2. Product Portfolio 18.3.10.3. Sales Footprint 18.3.10.4. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Virology Specimen Collection Market
